title: 1-Aminocyclobutanecarboxylic acid derivatives as novel structural elements in bioactive peptides: application to tuftsin analogs.
abstract: Four novel 2,4-methano amino acids (MAAs, 1-aminocyclobutane-1-carboxylic acids) were synthesized. These include the basic MAA analogs of lysine (16), ornithine (5), and arginine (6) and the neutral methanovaline (22), related to proline. The above MAAs, as well as the MAA analog of homothreonine (7), were incorporated into the peptide chain of the immunomodulatory peptide tuftsin, Thr-Lys-Pro-Arg, known to enhance several biological activities mediated by phagocytic cells. The synthetic methano tuftsin analogs were assayed for their ability to stimulate interleukin-6 (IL-6) secretion by mouse peritoneal macrophages and for their stability in human serum toward enzymatic degradation. It was found that, at 2 x 10(-7) M, [MThr1]tuftsin (24) and an isomer of [MVal3]tuftsin (27a) were considerably more active than the parent peptide in augmentation of cytokine release. [MOrn2]Tuftsin (25) was equally potent. The analogs [MThr1]tuftsin (24) and [MOrn2]tuftsin (25), both pertaining to the proteolytically sensitive Thr-Lys bond of tuftsin, exhibited high resistance to enzymatic hydrolysis as compared to tuftsin. Using specific rabbit anti-tuftsin antibodies in a competitive enzyme-linked immunosorbent assay (ELISA) revealed that none of the MAA analogs can cross-react with tuftsin. It may indicate that the peptides assume global structures different than that of tuftsin.
authors.affiliation: Department of Organic Chemistry, Weizmann Institute of Science, Rehovot, Israel.
authors.forename: E
authors.initials: E
authors.lastname: Gershonov
authors.forename: R
authors.initials: R
authors.lastname: Granoth
authors.forename: E
authors.initials: E
authors.lastname: Tzehoval
authors.forename: Y
authors.initials: Y
authors.lastname: Gaoni
authors.forename: M
authors.initials: M
authors.lastname: Fridkin
mesh_terms: D000596:Amino Acids / Q000737:chemistry; D000598:Amino Acids, Cyclic; D000818:Animals; D000906:Antibodies / Q000276:immunology / Q000378:metabolism; D002942:Circular Dichroism; D010450:Endopeptidases / Q000097:blood / Q000378:metabolism; D004797:Enzyme-Linked Immunosorbent Assay; D006801:Humans; D015850:Interleukin-6 / Q000378:metabolism; D017737:Macrophages, Peritoneal / Q000187:drug effects / Q000378:metabolism; D009682:Magnetic Resonance Spectroscopy; D013058:Mass Spectrometry; D051379:Mice; D015394:Molecular Structure; D010455:Peptides / Q000138:chemical synthesis* / Q000276:immunology / Q000378:metabolism / Q000494:pharmacology*; D014405:Tuftsin / Q000031:analogs & derivatives* / Q000032:analysis / Q000494:pharmacology
chemical_list: D000596:Amino Acids; D000598:Amino Acids, Cyclic; D000906:Antibodies; D015850:Interleukin-6; D010455:Peptides; C016987:1-aminocyclobutanecarboxylic acid; D010450:Endopeptidases; D014405:Tuftsin